1.44
price down icon7.10%   -0.11
after-market Handel nachbörslich: 1.48 0.04 +2.78%
loading
Schlusskurs vom Vortag:
$1.55
Offen:
$1.55
24-Stunden-Volumen:
717.44K
Relative Volume:
2.19
Marktkapitalisierung:
$76.31M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-51.47M
KGV:
-1.44
EPS:
-1
Netto-Cashflow:
$-47.50M
1W Leistung:
+0.00%
1M Leistung:
+0.00%
6M Leistung:
+11.63%
1J Leistung:
-4.64%
1-Tages-Spanne:
Value
$1.42
$1.56
1-Wochen-Bereich:
Value
$1.38
$1.59
52-Wochen-Spanne:
Value
$0.81
$1.82

Pmv Pharmaceuticals Inc Stock (PMVP) Company Profile

Name
Firmenname
Pmv Pharmaceuticals Inc
Name
Telefon
(609) 642-6670
Name
Adresse
400 ALEXANDER PARK DRIVE, PRINCETON
Name
Mitarbeiter
47
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-04
Name
Neueste SEC-Einreichungen
Name
PMVP's Discussions on Twitter

Vergleichen Sie PMVP mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
PMVP
Pmv Pharmaceuticals Inc
1.44 78.96M 0 -51.47M -47.50M -1.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
396.93 102.81B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
453.54 58.59B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
567.22 61.25B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
733.66 43.23B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
318.73 36.53B 3.81B -644.79M -669.77M -6.24

Pmv Pharmaceuticals Inc Stock (PMVP) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-11-08 Hochstufung Oppenheimer Perform → Outperform
2024-05-13 Eingeleitet Craig Hallum Buy
2024-04-12 Eingeleitet Jefferies Buy
2023-12-27 Eingeleitet Ladenburg Thalmann Buy
2022-03-02 Hochstufung Oppenheimer Perform → Outperform
2021-09-22 Hochstufung Goldman Neutral → Buy
2021-08-19 Eingeleitet Oppenheimer Perform
2021-08-02 Eingeleitet Guggenheim Buy
2021-07-29 Eingeleitet H.C. Wainwright Buy
2020-10-20 Eingeleitet BofA Securities Buy
2020-10-20 Eingeleitet Cowen Outperform
2020-10-20 Eingeleitet Evercore ISI Outperform
2020-10-20 Eingeleitet Goldman Neutral
Alle ansehen

Pmv Pharmaceuticals Inc Aktie (PMVP) Neueste Nachrichten

pulisher
Sep 03, 2025

Can PMV Pharmaceuticals Inc. reach all time highs this yearAnalyst Upgrade & Low Risk High Reward Ideas - khodrobank.com

Sep 03, 2025
pulisher
Sep 03, 2025

Using RSI to spot recovery in PMV Pharmaceuticals Inc.2025 Momentum Check & Risk Controlled Stock Pick Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Is PMV Pharmaceuticals Inc. stock a top performer YTD2025 Technical Patterns & Daily Volume Surge Trade Alerts - khodrobank.com

Sep 03, 2025
pulisher
Sep 03, 2025

Can machine learning forecast PMV Pharmaceuticals Inc. recoveryJuly 2025 Highlights & Low Risk Investment Opportunities - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Trend analysis for PMV Pharmaceuticals Inc. this weekQuarterly Portfolio Report & Long-Term Growth Portfolio Plans - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Is PMV Pharmaceuticals Inc. stock bottoming outRate Hike & Long-Term Safe Investment Ideas - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

How institutional ownership impacts PMV Pharmaceuticals Inc. stockJuly 2025 Recap & High Accuracy Investment Entry Signals - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

What the charts say about PMV Pharmaceuticals Inc. todayWeekly Market Report & Reliable Price Breakout Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Can PMV Pharmaceuticals Inc. hit a new high this month2025 Market Outlook & Fast Momentum Stock Entry Tips - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Chart based exit strategy for PMV Pharmaceuticals Inc.2025 Technical Overview & Stock Timing and Entry Methods - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Why PMV Pharmaceuticals Inc. is moving todayEarnings Growth Summary & Technical Buy Zone Confirmations - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Applying Elliott Wave Theory to PMV Pharmaceuticals Inc.Trade Exit Summary & Weekly Stock Breakout Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Applying big data sentiment scoring on PMV Pharmaceuticals Inc.July 2025 Patterns & Reliable Momentum Entry Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

What is PMV Pharmaceuticals Inc. s 5 year growth outlook2025 Retail Activity & Capital Efficiency Focused Ideas - khodrobank.com

Sep 03, 2025
pulisher
Sep 03, 2025

Will PMV Pharmaceuticals Inc. stock recover after earningsJuly 2025 Retail & Free Technical Pattern Based Buy Signals - khodrobank.com

Sep 03, 2025
pulisher
Sep 03, 2025

Candlestick signals on PMV Pharmaceuticals Inc. stock todayGap Up & Safe Capital Allocation Plans - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Does PMV Pharmaceuticals Inc. fit your quant trading model2025 Risk Factors & Consistent Growth Equity Picks - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Can you recover from losses in PMV Pharmaceuticals Inc.2025 Support & Resistance & Safe Entry Trade Signal Reports - Newser

Sep 03, 2025
pulisher
Sep 02, 2025

Is PMV Pharmaceuticals Inc. forming a bullish divergenceTrade Exit Summary & Low Drawdown Momentum Trade Ideas - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

How is PMV Pharmaceuticals Inc. managing supply chain issues2025 Major Catalysts & AI Driven Price Predictions - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Can PMV Pharmaceuticals Inc. deliver consistent EPS growthPortfolio Gains Report & Growth Focused Entry Point Reports - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

What chart patterns are forming on PMV Pharmaceuticals Inc.Weekly Trend Recap & Community Consensus Picks - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Visual trend scoring systems applied to PMV Pharmaceuticals Inc.July 2025 Analyst Calls & Daily Technical Stock Forecast Reports - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Predicting PMV Pharmaceuticals Inc. trend using moving averagesBuy Signal & Weekly Setup with ROI Potential - Newser

Sep 02, 2025
pulisher
Sep 01, 2025

Should value investors consider PMV Pharmaceuticals Inc.July 2025 Action & Fast Entry High Yield Tips - khodrobank.com

Sep 01, 2025
pulisher
Sep 01, 2025

Multi factor analysis applied to PMV Pharmaceuticals Inc.CEO Change & Safe Capital Investment Plans - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Can momentum traders help lift PMV Pharmaceuticals Inc.Portfolio Gains Summary & Safe Entry Zone Identification - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Bear Alert: Will PMV Pharmaceuticals Inc. outperform during market ralliesWall Street Watch & Safe Capital Allocation Plans - khodrobank.com

Sep 01, 2025
pulisher
Sep 01, 2025

Is PMV Pharmaceuticals Inc. still worth holding after the dipTrade Analysis Report & Fast Moving Stock Trade Plans - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Should you wait for a breakout in PMV Pharmaceuticals Inc.2025 Dividend Review & Technical Buy Zone Confirmation - Newser

Sep 01, 2025
pulisher
Aug 31, 2025

Applying Wyckoff theory to PMV Pharmaceuticals Inc. stockBear Alert & Fast Moving Stock Trade Plans - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Long term hold vs stop loss in PMV Pharmaceuticals Inc.July 2025 Analyst Calls & Low Risk Investment Opportunities - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

What to do if you’re stuck in PMV Pharmaceuticals Inc.Portfolio Value Report & Safe Entry Momentum Tips - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Heatmap analysis for PMV Pharmaceuticals Inc. and competitorsJuly 2025 Levels & Reliable Breakout Forecasts - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Why PMV Pharmaceuticals Inc. stock attracts strong analyst attentionPortfolio Value Summary & Real-Time Stock Entry Alerts - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Risk vs reward if holding onto PMV Pharmaceuticals Inc.July 2025 Breakouts & Safe Swing Trade Setups - Newser

Aug 31, 2025

Finanzdaten der Pmv Pharmaceuticals Inc-Aktie (PMVP)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Pmv Pharmaceuticals Inc-Aktie (PMVP) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Jalota Deepika
Chief Development Officer
Jul 01 '25
Sale
1.06
33,065
35,198
89,959
Carulli Michael
Chief Financial Officer
Jul 01 '25
Sale
1.06
28,249
30,077
60,146
Mack David Henry
President and CEO
Jul 01 '25
Sale
1.06
58,411
62,179
536,133
Mack David Henry
President and CEO
Dec 03 '24
Option Exercise
0.53
91,750
48,628
534,210
Mack David Henry
President and CEO
Jan 03 '25
Option Exercise
0.53
17,709
9,386
551,919
Jalota Deepika
Chief Development Officer
Sep 11 '24
Sale
1.50
7,218
10,853
118,283
Carulli Michael
Chief Financial Officer
Sep 11 '24
Sale
1.50
2,891
4,347
88,395
$85.44
price down icon 1.75%
$27.38
price up icon 1.11%
$23.80
price up icon 1.19%
$103.50
price up icon 3.07%
$142.53
price down icon 0.68%
biotechnology ONC
$318.73
price down icon 5.21%
Kapitalisierung:     |  Volumen (24h):